Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Trump media deal advisers were reprimanded by SEC, Marjorie Taylor Greene buys Trump-linked SPAC during height of trading frenzy, and DocGo secures multiple new contracts
Trump Media Deal Partner Advisers Were Reprimanded by the SEC
The financiers – Abraham Cinta, Sergio Camarero, Carlos Lopez and Jesus Emilio Hoyos Quintero – are managing partners of ARC Group Ltd, a Shanghai-based investment bank listed in a regulatory filing as a financial adviser to Digital World Acquisition Corp (NASDAQ:DWAC), the shell company merging with the former U.S. President’s venture.
Digital World touted ARC in one filing as adviser that had contacts in government, corporate, investment and advisory worlds and would help it “get access to quality deal pipeline.”
A review of regulatory filings shows that while ARC has been actively involved in the creation of SPACs, especially over the past two years, its executives ran into trouble with the U.S. SEC in 2017. The regulator sued to block the IPOs of three companies where the four men had leading roles, accusing them of misrepresenting their connections, misstating the nature and scope of their businesses and failing to cooperate with regulators.
READMarjorie Taylor Greene Buys Trump-Linked SPAC During Height of Trading Frenzy
Representative Marjorie Taylor Greene, one of Donald Trump’s most vocal supporters, bought as much as $50,000 worth of shares in a blank-check company tied to the former president during a frenzied day of trading for the firm last week.
After skyrocketing on Friday, shares in Digital World Acquisition Corp.(NASDAQ:DWAC) have since fallen about 22% this week. The stock was at around $73 a share midday on Thursday, after trading for as much as $175 last week.
It’s unclear how much money, if any, Greene may have lost so far. In a filing, the Georgia Republican disclosed that she bought between $15,001 and $50,000 in the company on Friday but didn’t specify the purchase price. The stock gyrated that day, falling as low as $67.96 before closing at $94.20.
READDocGo Secures Multiple New Contracts to Expand its Services Nationwide
DocGo, a leading provider of last-mile Mobile Health services and integrated medical mobility solutions that has entered into an agreement to merge with Motion Acquisition Corp. (NASDAQ: MOTN), has secured multiple new contracts that will enable its services to reach a wider patient population.
Expanding its presence in key markets across the country, DocGo is introducing additional services including Mobile Health for the residents of San Diego, CA and the homeless population in Delaware County, PA, monoclonal antibody infusion treatment for patients in Arizona, and COVID-19 testing at schools in Philadelphia and South Carolina.
READ
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...